• Info
  • Significant Ownership

Significant Ownership of TCG Crossover GP I, LLC

Signature - Title
/s/ Craig Skaling - Authorized Signatory
Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TCG Crossover GP I, LLC.

Notify me when TCG Crossover GP I, LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of TCG Crossover GP I, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ABVX Abivax SA Ordinary Shares, par value Euro 0.01 per share 9.1% $603,774,500 7,111,596 Chen Yu 30 Sep 2025
TYRA Tyra Biosciences, Inc. Common Stock, par value $0.0001 per share 5.7% $23,068,900 2,898,103 TCG Crossover GP I, LLC 27 Feb 2025
TRDA Entrada Therapeutics, Inc. Common Stock, par value $0.0001 per share 5% $11,849,186 1,917,344 TCG Crossover GP I, LLC 19 Nov 2025
COGT Cogent Biosciences, Inc. Common Stock, par value $0.001 per share 4.8% $97,621,606 6,798,162 TCG Crossover GP I, LLC 30 Sep 2025
CGON CG Oncology, Inc. Common Stock, par value $0.0001 per share 4.8% $57,218,512 3,670,206 TCG Crossover GP I, LLC 31 Mar 2025
UPB Upstream Bio, Inc. Common Stock, par value $0.001 per share 3.9% $39,825,671 -$12,879,413 2,117,103 -24% TCG Crossover GP I, LLC 30 Sep 2025
CMPS COMPASS Pathways plc Ordinary Shares, nominal value 0.008 per share 3.9% $18,556,980 3,858,000 Chen Yu 30 Jun 2025
JBIO Jade Biosciences, Inc. Common Stock, $0.0001 par value per share 0.2% 64,023 TCG Crossover GP I, LLC 28 Apr 2025
ANTX AN2 Therapeutics, Inc. Common Stock, $0.00001 par value 0% $0 0 TCG Crossover GP I, LLC 31 Dec 2024

Schedules 13D/G Reported by TCG Crossover GP I, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.